12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

  • CytomX Therapeutics CTMX stock increased by 154.6% to $4.15 during Wednesday's regular session. The market value of their outstanding shares is at $281.0 million.
  • Cyclacel Pharmaceuticals CYCC shares increased by 36.79% to $2.9. The market value of their outstanding shares is at $3.8 million.
  • Akanda AKAN shares increased by 33.87% to $0.12. The company's market cap stands at $1.4 million.
  • Surmodics SRDX shares increased by 30.14% to $33.44. The market value of their outstanding shares is at $475.9 million. As per the news, the Q2 earnings report came out today.
  • Psyence Biomedical PBM shares increased by 27.81% to $1.15. The market value of their outstanding shares is at $15.3 million.
  • TransMedics Gr TMDX shares rose 27.75% to $120.26. The company's market cap stands at $3.9 billion. As per the press release, Q1 earnings came out yesterday.

Losers

  • CVRx CVRX stock declined by 36.9% to $9.79 during Wednesday's regular session. The market value of their outstanding shares is at $211.4 million. As per the press release, Q1 earnings came out yesterday.
  • Tilray Brands TLRY shares declined by 19.65% to $1.98. The market value of their outstanding shares is at $1.5 billion.
  • cbdMD YCBD stock fell 19.11% to $0.89. The company's market cap stands at $2.7 million.
  • BiomX PHGE stock decreased by 18.38% to $0.39. The company's market cap stands at $21.5 million.
  • CVS Health CVS stock fell 16.94% to $56.24. The market value of their outstanding shares is at $70.8 billion. The company's, Q1 earnings came out today.
  • Mobile-health Network MNDR stock declined by 15.5% to $20.83. The company's market cap stands at $708.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!